A transformation in neurosurgery

$10 million for Neuro-led project seeking new Alzheimer’s biomarkers

A groundbreaking project led by Dr. Pedro Rosa-Neto at The Neuro (Montreal Neurological Institute-Hospital) of McGill University has received a major boost thanks to a $10-million grant from the Weston Family Foundation.

Scientists reveal how the brain uses objects to find direction

We take our understanding of where we are for granted, until we lose it. When we get lost in nature or a new city, our eyes and brains kick into gear, seeking familiar objects that tell us where we are.

Sylvain Baillet inducted into the Royal Society of Canada

Sylvain Baillet, PhD, a global leader in brain imaging and systems neuroscience, has been inducted into the Royal Society of Canada, one of the nation’s highest academic honours.

Human instruction with artificial intelligence guidance provided best results in neurosurgical training

Artificial intelligence (AI) is becoming a powerful new tool in training and education, including in the field of neurosurgery. Yet a new study suggests that AI tutoring provides better results when paired with human instruction.

Alan Evans receives Order of Canada

A career that took an uncharted trajectory has been recognized with the Order of Canada, one of the country’s top honours.

AI analysis of healthcare records reveals key factors in autism diagnosis

Without clear and effective biological tests for autism based on genes, brain or blood measurements, diagnosis today still largely depends on clinical assessment. The standard way of doing this is by observing how the individual fits the criteria for autism listed in gold standard manuals like the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5).

Expanding access to specialized healthcare across Quebec: ECHO Superhub at The Neuro

A healthcare telementoring program housed at The Neuro and supported by the Transforming Autism Care Consortium (TACC) is expanding its reach after achieving designation as an ECHO Superhub.

Latest Alzheimer’s drug shown less effective in females than males

Since becoming only the second Alzheimer’s-modifying drug to gain American FDA approval in 2023, sales of lecanemab, known by its brand name Leqembi, have risen steadily, reaching $87-million USD in the last quarter of 2024.

Genetic sequencing project receives more than $8 million in funding

A project led by Ziv Gan-Or, MD, PhD, at The Neuro (Montreal Neurological Institute-Hospital) of McGill University and Martine Tétreault, PhD, at Université de Montréal has received more than $8 million to sequence the genomes of 8,700 people, to map the role of genetics in neurological disorders.

Project to create AI model for ALS receives Génome Québec funding

Achievements of clinicians and scientists recognized with King Charles III Coronation Medals

Five clinicians and scientists at The Neuro have been awarded King Charles III Coronation Medals in recognition of their contributions to our understanding of neurological disease. The Coronation Medal commemorates the Coronation of His Majesty King Charles III as King of Canada. The medal is administered by the Chancellery of Honours at Rideau Hall.

Prescribing anti-swelling drug reduces immune response weeks after last dose

Swelling caused by brain cancer is a problem that can lead to serious side effects and even death. While controlling swelling is important, a new study shows that a commonly prescribed anti-swelling drug suppresses the immune system for weeks after dosage, inhibiting the body’s ability to fight the cancer.

Six principal investigators from The Neuro receive CIHR grants

An open solution to improving research reproducibility

Structural Genomics Consortium researchers at The Neuro (Montreal Neurological Institute-Hospital) of McGill University, in collaboration with scientists from 11 major antibody manufacturers representing approximately 80 per cent of global renewable antibody production, have developed and standardized an Open Science platform to characterize research antibodies.